首页 | 本学科首页   官方微博 | 高级检索  
     

乳腺术后三阴方干预三阴性乳腺癌化疗脑症状临床研究
引用本文:陈佳静,刘胜,秦悦农,孙霃平,鲍以嘉,徐一云,王怡. 乳腺术后三阴方干预三阴性乳腺癌化疗脑症状临床研究[J]. 世界中医药, 2024, 0(5)
作者姓名:陈佳静  刘胜  秦悦农  孙霃平  鲍以嘉  徐一云  王怡
作者单位:1 上海中医药大学附属龙华医院中西结合乳腺科,上海,200032; 2 上海中医药大学,上海,200120
基金项目:上海中医药大学附属龙华医院第二轮《促进市级医院临床技能与临床创新三年行动计划》重大临床研究项目(SHDC2020CR1050B)——中西医结合治疗早期三阴性乳腺癌多中心随机对照研究;上海市科学技术委员会中西结合综合治疗三阴性乳腺癌研究(20Z21900300);上海市2023年度“科技创新行动计划”科技成果转化服务体系建设项目(23Y11920700)——黄芩汤联合阿贝西利治疗HR阳性晚期乳腺癌患者“增效减毒效应”的临床循证评价研究
摘    要:目的:观察评价乳腺术后三阴方对三阴性乳腺癌化疗相关认知障碍临床症状的影响。方法:采用前瞻性队列研究设计,选取2020年12月至2021年6月上海龙华医院、上海肿瘤医院化疗患者130例作为研究对象,按照是否服用乳腺术后三阴方分为对照组(n=64)和观察组(n=66),对照组给予常规治疗,观察组给予中药乳腺术后三阴方,餐后温服,疗程3个月。治疗结束后,观察癌症患者功能评估-认知功能量表(FACT-cog)评分,神经心理学测验,中医症状及安全性指标。结果:随访结束后对照组认知异常为49例,占79.03%,观察组认知异常为47例,占75.81%,暴露因素相对危险度(RR)为0.93。观察组患者生命质量的提升与对照组比较,差异均有统计学意义(均P<0.05),对照组生命质量与治疗前比较有所提高,其余相关症状均逐渐加重。FACT-cog各维度症状与乳腺术后中医症状存在相关性。随访3个月后,观察组患者中医症状积分显著低于对照组(P<0.05)。结论:乳腺术后三阴方对认知能力的提升作用尚未明确,但其通过缓解化疗不适症状改善三阴性乳腺癌患者自我感知到的认知障碍相关症状,且对三阴性乳腺癌化疗相关认知能力的减退可能具有预防作用。

关 键 词:三阴性乳腺癌;化疗相关认知障碍;化疗脑;情志病;神志病;队列研究;神经心理学测试;乳腺术后三阴方
收稿时间:2022-08-15

Clinical Study of Sanyin Formula in Treating Cognitive Impairment Related to Chemotherapy for Triple Negative Breast Cancer
CHEN Jiajing,LIU Sheng,QIN Yuenong,SUN Chenping,BAO Yiji,XU Yiyun,WANG Yi. Clinical Study of Sanyin Formula in Treating Cognitive Impairment Related to Chemotherapy for Triple Negative Breast Cancer[J]. World Chinese Medicine, 2024, 0(5)
Authors:CHEN Jiajing  LIU Sheng  QIN Yuenong  SUN Chenping  BAO Yiji  XU Yiyun  WANG Yi
Affiliation:1 Galactophore Department of Integrated Traditional Chinese and Western Medicine,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese medicine,Shanghai 200032,China; 2 Shanghai University of Traditional Chinese Medicine,Shanghai 200120,China
Abstract:To observe and evaluate the effects of Sanyin Formula on cognitive impairment related to chemotherapy for triple negative breast cancer(TNBC).Methods:A prospective cohort study was carried out for 130 TNBC patients receiving chemotherapy at Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine and Fudan University Shanghai Cancer Center from December 2020 to June 2021.According to receiving Sanyin Formula or not after chemotherapy,the patients were assigned into a control group(n=64) and an observation group(n=66).The control group received conventional treatment,and the observation group received Sanyin Formula after chemotherapy.The drug was taken warm after meals for 3 months.After treatment,the FACT-cog score,neuropsychological test results,TCM symptoms,and safety indicators of the patients were recorded.Results:After follow-up,there were 49(79.03%) and 47(75.81%) patients with cognitive abnormalities in the control and observation groups,respectively.The relative risk of exposure factors was 0.93.The improvement of quality of life in the observation group was different from that in the control group(all P<0.05).In the control group,only the quality of life was improved,while the other symptoms were gradually aggravated.The symptoms of FACT-cog were correlated with TCM symptoms after chemotherapy.After 3 months of follow-up,TCM symptom scores in the observation group were lower than those in the control group(P<0.05).Conclusion:Although the effect of Sanyin Formula on the improvement of cognitive ability after chemotherapy remains unclear,this formula can alleviate the self-perceived symptoms of cognitive impairment in TNBC patients by relieving discomfort symptoms related to chemotherapy and may exert a preventive effect on the cognitive decline related to chemotherapy.
Keywords:Triple negative breast cancer   Chemotherapy-related cognitive impairment   Chemo brain   Emotional disorders   Mental illness   Cohort study   Neuropsychological test   Sanyin Formula after Chemotherapy for Breast Cancer
点击此处可从《世界中医药》浏览原始摘要信息
点击此处可从《世界中医药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号